Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Notes Payables (2022 - 2025)

Historic Notes Payables for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to $195658.0.

  • Neuraxis' Notes Payables rose 3248.06% to $195658.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $195658.0, marking a year-over-year increase of 3248.06%. This contributed to the annual value of $154152.0 for FY2024, which is 411.31% up from last year.
  • Neuraxis' Notes Payables amounted to $195658.0 in Q3 2025, which was up 3248.06% from $121433.0 recorded in Q2 2025.
  • Neuraxis' 5-year Notes Payables high stood at $4.7 million for Q2 2024, and its period low was $84307.0 during Q1 2025.
  • Its 4-year average for Notes Payables is $774510.3, with a median of $194249.0 in 2023.
  • Its Notes Payables has fluctuated over the past 5 years, first surged by 28839.21% in 2024, then tumbled by 9743.19% in 2025.
  • Neuraxis' Notes Payables (Quarter) stood at $228342.0 in 2022, then plummeted by 35.16% to $148062.0 in 2023, then rose by 4.11% to $154152.0 in 2024, then increased by 26.93% to $195658.0 in 2025.
  • Its Notes Payables stands at $195658.0 for Q3 2025, versus $121433.0 for Q2 2025 and $84307.0 for Q1 2025.